Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2017 Aug;7(4):582–597. doi: 10.1007/s13346-017-0379-2

Fig. 13.

Fig. 13

Fold expression of cardiac hypertrophy markers in RL-14 cells after treatment at 10 µM for 24 h of doxorubicin, DoxQ, or quercetin. The mRNA expression of a BNP, b α-MHC, and c β-MHC in RL-14 cells. The mRNA expression was quantified by RT-PCR and normalized to β-actin as a housekeeping gene. N = 6; mean ± SEM.*P < 0.05 compared to doxorubicin, +P < 0.05 compared to control